Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 10, 2011
Nuclear receptor CAR (NR1I3) is essential for DDC-induced liver injury and oval cell proliferation in mouse liverYuichi Yamazaki, Rick Moore, Masahiko NegishiMolecular Pharmacology|August 2, 2015
Pregnane X Receptor Represses HNF4α Gene to Induce Insulin-Like Growth Factor-Binding Protein IGFBP1 that Alters Morphology of and Migrates HepG2 CellsSusumu Kodama, Yuichi Yamazaki, Masahiko NegishiWorld Journal of Gastroenterology|January 24, 2022
Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19Ken Sato, Yuichi Yamazaki, Toshio UraokaCurrent Drug Metabolism|September 11, 2008
New insights on the xenobiotic-sensing nuclear receptors in liver diseases--CAR and PXR--Satoru Kakizaki, Yuichi Yamazaki, Daichi Takizawa, et al.Current Drug Targets|November 21, 2009
Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver diseaseSatoru Kakizaki, Daichi Takizawa, Hiroki Tojima, et al.Acta Medica Okayama|February 27, 2013
A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohortsHiroaki Hashizume, Ken Sato, Yuichi Yamazaki, et al.Carcinogenesis|December 22, 2010
Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitisDaichi Takizawa, Satoru Kakizaki, Norio Horiguchi, et al.Journal of Medical Virology|March 18, 2015
Full genome analysis of a European-type genotype 3 hepatitis E virus variant obtained from a Japanese patient with autochthonous acute hepatitis ESuguru Takeuchi, Yuichi Yamazaki, Ken Sato, et al.Materials (Basel, Switzerland)|May 13, 2023
Boron-Related Defects in N-Type 4H-SiC Schottky Barrier DiodesTihomir Knezevic, Eva Jelavić, Yuichi Yamazaki, et al.Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver diseaseSatoru Kakizaki, Daichi Takizawa, Hiroki Tojima, et al.Pageof 9